EventsThe 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published
This submission belongs to the session S6. New Modalities in Drug Discovery of the event The 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published date
28 Oct, 2026
Academic Editor
author-avatarMaria Emília Sousa
Contribution&Funding
Conceptualization,
[Cláudio Rodrigues Bispo] ; [Beate Saegesser Santos]
Validation,
[Marques Leonel Silva]
Formal analysis,
[Cláudio Rodrigues Bispo] ; [Marques Leonel Silva]
Data curation,
[Karolyne Santos da Silva]
Writing - original draft,
[Cláudio Rodrigues Bispo] ; [Marques Leonel Silva]
Writing - review,
[editing] ; [Karolyne Santos da Silva] ; [Beate Saegesser Santos]
Visualization,
[Karolyne Santos da Silva]
Supervision,
[Beate Saegesser Santos]
Project administration,
[Beate Saegesser Santos]
Funding acquisition,
[Beate Saegesser Santos]
Funding: This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq; Grant No. 421369/2023-0) and by scholarships awarded to C.H. Bispo and M.L. Silva by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES
Citation
Cláudio Rodrigues Bispo, Marques Leonel Silva, Karolyne Santos da Silva, Beate Saegesser Santos, Effect of pre-incubation time on riboflavin–candida albicans interactions prior to photodynamic inactivation assessed by spectrophotometry, in Proceedings of The 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics, 1 November–30 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Effect of pre-incubation time on riboflavin–candida albicans interactions prior to photodynamic inactivation assessed by spectrophotometry

Marques Leonel Silva 1
Karolyne Santos da Silva 1
1. Pharmaceutical Sciences, Federal University of Pernambuco, Recife, Pernambuco, Brazil
Abstract

Antimicrobial photodynamic inactivation (aPDI) has emerged as a promising approach for controlling Candida albicans, relying on the interaction between a photosensitizer, light, and molecular oxygen to generate cytotoxic reactive oxygen species. Photodynamic efficacy is strongly influenced by photosensitizer availability and its interaction with microbial cells before irradiation, making pre-incubation time a relevant parameter for treatment optimization. Riboflavin is a biocompatible, naturally occurring photosensitizer with favorable photochemical properties; however, the kinetics of its association with fungal cells and the influence of pre-incubation time remain poorly understood.

C. albicans ATCC 10231 suspensions (10⁵ CFU/mL) were incubated with 400 µmol L⁻¹ riboflavin in a 1:1 (v/v) ratio for different pre-incubation times (30–120 min) in 24-well plates under agitation (~400 rpm) and protected from light. Samples were then centrifuged at 4,000 rpm for 5 min, and riboflavin remaining in the supernatant was quantified spectrophotometrically at 450 nm.

Pre-incubation time markedly influenced riboflavin association with C. albicans. After 30 min, approximately 30% of the photosensitizer was associated with fungal cells, increasing to 75% after 60 min. A plateau was reached at 90 min, while at 120 min the available riboflavin was nearly depleted, suggesting that the initial concentration limited further time-dependent association.

Spectrophotometry provided a simple approach to optimize photosensitizer pre-incubation time, avoiding unnecessarily prolonged PS–microorganism contact. This strategy may be extended to other photosensitizers, particularly emerging molecules under investigation for photodynamic applications.

Keywords
photodynamic therapy,
fungal inactivation
riboflavin
Mechanically Activated Anticonvulsant Lacosamide: Study of Long-Term Changes in Physico-Chemical and Pharmacokinetic Properties
From Conformational Control to GPCR Recognition: Structure-Guided Design of Short Peptide and Peptidomimetic Ligands